Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see stocks rose on Tuesday. Investors are betting that China will phase out its stringent Covid Zero policy. The news stems from an unverified social media post that Beijing is looking to gradually unwind restrictions - and US-listed Chinese stocks soared as a result. The struggles of today's market is providing one of the biggest investment opportunities in history. Alpesh Patel, the Financial Times No. 1 Stock Market Forecasting Champion, is showing investors how they can protect their money AND turn this tough market into the biggest profit windfall of their lives. Click here to learn about a powerful signal that separates winners and losers in rough markets. Here's a look at the top-moving stocks this morning. Abiomed, Inc.(Nasdaq: ABMD) Abiomed is up 48.38% premarket afterthe biotech company reached an agreement to be acquired by Johnson & Johnson (JNJ). The deal consists of an upfront payment of $380.00 per share in cash, plus an enterprise value of approximately $16.6 billion which includes cash acquired. The transaction will broaden Johnson & Johnson MedTech's position as a growing cardiovascular innovator. Predicting major swings in the market isn't easy, but knowing how to track insider buying can give you an edge. See how our Head Fundamental Tactician Karim Rahemtulla tracks insider buying as part of his Insider Matrix. This strategy has proven to lead to gains as high as $2,250%. Click here to discover the Insider Matrix. Carvana (NYSE: CVNA) Carvana is up 11.97% premarket after JPMorgan upgraded its stock to neutral, announcing a $20 price target. Right now Carvana is at 13.53 per share. The analyst said the car retailer is 'not out of the woods' yet, but noted the company can better manage through its liquidity. |
No comments:
Post a Comment